Immunohistochemical detection of thymidylate synthase in advanced gastric cancer: A prognostic indicator in patients undergoing gastrectomy followed by adjuvant chemotherapy with 5-fluoropyrimidines

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 805-810

  Suda, Yasuo ^a,d   Kuwashima, Yoshio ^b   Tanaka, Yoichi ^a   Uchida, Kenji ^a   Akazawa, Syugo ^c  

^a Division of Abdominal Surgery   (Japan)

^b Clinical Pathology   (Japan)

^c Gastroenterol Saitama Cancer C   (Japan)

^d SAITAMA CANCER CENTER   (Japan)

Author keywords

5 Fluorouracil; Gastric cancer; Immunohistochemical expression; Prognostic factor; Tegafur; Thymidylate synthase; UFT

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROPYRIMIDINE; FLUOROURACIL; FORMALDEHYDE; MITOMYCIN C; PARAFFIN; TEGAFUR; THYMIDYLATE SYNTHASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW; CANCER SURVIVAL; CARCINOMA CELL; FEMALE; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STAINING; STOMACH CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME;

EID: 0032950876     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Johnston PG, Lenz H-J, Leichman CG, et al: Thymidylate Synthase Gene and Protein Expression Correlate and Are Associated with Response to 5-Fluorouracil in Human Colorectal and Gastric Tumors: Cancer Res 55: 1407-1412, 1995.
2. Johnston PG, Fisher ER, Rockett HE, et al: The Role of Thymidylate Synthase Expression in Prognosis and Outcome of Adjuvant Chemotherapy in Patients with Rectal Cancer: J Clin Oncol 12: 2640-2647, 1994.
3. Sanguedolce R, Brumarescu I, Dardanon G, et al: Thymidylate Synthase Level and DNA Ploidy Pattern as Possible Prognostic Factor in Human Colorectal Cancer; A Preliminary study: Anticancer Res 15: 901-906, 1995.
4. Lenz H-J, Leichman CG, Donenberg KD, et al: Thymidylate Synthase mRNA Level in Adenocarcinoma of the Stomach: A Predictor for Primary Tumor Response and Overall Survival: J Clin Oncol 14: 176-182, 1996.
5. Okabe H, Tsujimoto H and Fukushima M: Preparation of antibodies against recombinant human thymidylate synthase for the detection of its intratumoral level and the application to sensitivity-study of 5-fluorouracil : Oncol Rep 4: 685-690, 1997.
6. Hermanek P and Sobin LH TNM: Classification of Malignant Tumours, 4th Ed. Springer Verlag Berlin 43-46, 1987.
7. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques ; a comparison between ABC and unlabeled antibody (PAP) procedures: J Histochem Cytochem 29: 577-580, 1981.
8. Peters GJ, van der Wilt CL, van Groenigen CJ, et al: Thymidylate Synthase Inhibition After Administration of Fluorouracil With or Without Leucovorin in Colon Cancer Patients: Implication for Treatment with Fluorouracil: J Clin Oncol 12: 2035-2042, 1994.
9. Leichman L, Lenz H-J, Leichman CG, et al: Quantitation of Intratumoral Thymidylate Synthase Expression Predicts for Resistance to Protracted Infusion of 5-fluorouracil and Weekly Leucovorin in Disseminated Colorectal Cancers; Preliminary Report from an Ongoing Trial: Eur J Cancer 31A: 1306-1310, 1995.
10. Beck A, Etienne MC, Chéradame S et al: A Role for Dyhydropyrimidine Dehydrogenase and Thymidylate Synthase in Tumours sensitivity to fluorouracil: Eur J Cancer 30A: 1517-1522, 1994.